Caffeic acid phenethyl ester ameliorated ototoxicity induced by cisplatin in rats

Journal of Chemotherapy

Volumn 16, Issue 4, 2004, Pages 381-387

  Kizilay, A ^a,b   Kalcioglu, M T ^a   Ozerol, E ^a   Iraz, M ^a   Gulec, M ^a   Akyol, O ^a   Ozturan, O ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Antioxidant agents; Caffeic acid phenethyl ester; Cisplatin; Otoacoustic emissions; Ototoxicity; Outer hair cells; Rat

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; CISPLATIN; CISPLATINUM EBEWE; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CHEMICAL ANALYSIS; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; ENZYME ACTIVITY; FEMALE; FREQUENCY MODULATION; INFERIOR CAVA VEIN; NONHUMAN; OTOTOXICITY; RAT;

EID: 3943076441     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.4.381     Document Type: Article

References (24)

1. Campbell KC, Rybak LP, Meech RP, Hughes L. D-methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res 1996; 102 (1-2): 90-98.
2. Fausti S, Henry JA, Schaffer HI, Olson DJ, Frey RH, Bagby GC Jr. High frequency monitoring for early detection of cisplatin ototoxicity. Arch Otolaryngol Head Neck Surg 1993; 119 (6): 661-666.
3. Schweitzer VG. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. Laryngoscope 1993; 103 (4 Pt 2): 1-52.
4. Ravi R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 1995; 76 (6): 386-394.
5. Rybak LP, Whitworth C, Somani S. Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope 1999; 109(11): 1740-1744.
6. Kopke RD, Liu W, Gabaizadeh R, et al. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidants molecules on cisplatin-induced damage of auditory hair cells. Am J Otol 1997; 18 (5): 559-571.
7. Akyol O, Herken H, Uz E, et al. The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26 (5): 995-1005.
8. Hepsen IF, Bayramlar H, Gultek A, Ozen S, Tilgen F, Evereklioglu C. Caffeic acid phenethyl ester to inhibit posterior capsule opacification in rabbits. J Cataract Refract Surg 1997; 23 (10): 1572-1576.
9. Grunberger D, Banerjee R, Eisinger K, et al. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 1988; 44 (3): 230-232.
10. Khayyal MT, el-Ghazaly MA, el-Khatib AS. Mechanisms involved in the antiinflammatory effect of propolis extract. Drugs Exp Clin Res 1993; 19 (5): 197-203.
11. Hepsen IF, Er H, Cekic O. Topically applied water extract of propolis to suppress corneal neovascularization in rabbits. Ophthalmic Res 1999; 31 (6): 426-431.
12. Sud'ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 1993; 329 (1-2): 21-24.
13. Koltuksuz U, Irmak MK, Karaman A, et al. Testicular nitric oxide levels after unilateral testicular torsion/detorsion in rats pretreated with caffeic acid phenethyl ester. Urol. Res 2000; 28 (6): 360-363.
14. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36 (8 Pt 1): 1440-1443.
15. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34 (3): 497-500.
16. Prajda N, Weber G. Malign transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett 1975; 59 (2): 245-249.
17. Sockalingam R, Freeman S, Cherny TL, Sohmer H. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emission in laboratory animals. Am J Otol 2000; 21 (4): 521-527.
18. Tampakopoulou DA, Sie KC. Cisplatin ototoxicity in developing gerbils. Hear Res 1999; 132 (1-2): 51-59.
19. Lopez-Gonzalez MA, Guerrero JM, Rojas F, Delgado F. Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants. J Pineal Res 2000; 28 (2): 73-80.
20. Ozturan O, Jerger J, Lew H, Lynch GR. Monitoring of cisplatin ototoxicity by distortion-product otoacoustic emissions. Auris Nasus Larynx 1996; 23: 147-151.
21. Ilhan A, Koltuksuz U, Ozen S, Uz E, Ciralik H, Akyol O. The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. Eur J Cardiothorac Surg 1999; 16 (4): 458-463.
22. Irmak MK, Koltuksuz U, Kutlu NO, et al. The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with alpha-tocopherol in rat kidneys. Urol Res 2001; 29 (3): 190-193.
23. Uz E, Sogut S, Sahin S, et al. The protective role of caffeic acid phenethyl ester (CAPE) on testicular tissue after testicular torsion and detorsion. World J Urol 2002; 20 (4): 264-270.
24. Sahin S, Sogut S, Ozyurt H, Uz E, Ilhan A, Akyol O. Tissue xanthine oxidase activity and nitric oxide levels after spinal cord ischemia/reperfusion injury in rabbits: comparison of caffeic acid phenethyl ester (CAPE) and methylprednisolone. Neurosci Res Commun 2002; 31: 111-121.